Tyck till om SwePub Sök
här!
Sökning: WFRF:(Bauer Peter)
> Eriksson Mikael
> Pesonen Tommi >
KIT and PDGFRA Muta...
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
-
- Joensuu, Heikki (författare)
- Helsinki University Central Hospital
-
- Wardelmann, Eva (författare)
- University Hospital Münster
-
- Eriksson, Mikael (författare)
- Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital
-
visa fler...
-
- Reichardt, Annette (författare)
- HELIOS Klinikum Berlin-Buch
-
- Hall, Kirsten Sundby (författare)
- Norwegian Radium Hospital
-
- Schütte, Jochen (författare)
- Alfried Krupp Krankenhaus
-
- Cameron, Silke (författare)
- University of Göttingen
-
- Hohenberger, Peter (författare)
- Heidelberg University
-
- Sihto, Harri (författare)
- University of Helsinki
-
- Jost, Philipp J. (författare)
- Klinikum rechts der Isar
-
- Lindner, Lars H. (författare)
- University Hospital Munich
-
- Bauer, Sebastian (författare)
- University Hospital Essen
-
- Nilsson, Bengt (författare)
- Sahlgrenska University Hospital
-
- Kallio, Raija (författare)
- Oulu University Hospital
-
Pesonen, Tommi (författare)
-
- Reichardt, Peter (författare)
- HELIOS Klinikum Berlin-Buch
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska 7 s.
-
Ingår i: Clinical Cancer Research. - 1078-0432. ; 29:17, s. 3313-3319
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Purpose: Limited data are available about the influence of KIT and PDGFRA mutations on overall survival (OS) of patients with gastrointestinal stromal tumor (GIST) treated with adjuvant imatinib. Patients and Methods: The Scandinavian Sarcoma Group XVIII/AIO multicenter trial accrued 400 patients with a high risk for GIST recurrence after macroscopically complete surgery between February 4, 2004, and September 29, 2008. The patients received adjuvant imatinib 400 mg/day for either 1 year or 3 years based on random allocation. We analyzed using conventional sequencing KIT and PDGFRA mutations centrally from 341 (85%) patients who had localized, centrally confirmed GIST, and correlated the results with recurrence-free survival (RFS) and OS in exploratory analyses. Results: During a median follow-up time of 10 years, 164 RFS events and 76 deaths occurred. Most patients were re-treated with imatinib when GIST recurred. Patients with KIT exon 11 deletion or indel mutation treated with 3 years of adjuvant imatinib survived longer than patients treated for 1 year [10-year OS 86% versus 64%, respectively; HR, 0.34; 95% confidence interval (CI), 0.15-0.72; P 0.007], and also had longer RFS (10-year RFS 47% versus 29%; HR, 0.48; 95% CI, 0.31-0.74; P < 0.001). Patients with KIT exon 9 mutation had unfavorable OS regardless of the duration of adjuvant imatinib. Conclusions: Compared with 1 year of imatinib, 3 years of adjuvant imatinib led to 66% reduction in the estimated risk of death and a high 10-year OS rate in the subset of patients with a KIT exon 11 deletion/indel mutation.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Joensuu, Heikki
-
Wardelmann, Eva
-
Eriksson, Mikael
-
Reichardt, Annet ...
-
Hall, Kirsten Su ...
-
Schütte, Jochen
-
visa fler...
-
Cameron, Silke
-
Hohenberger, Pet ...
-
Sihto, Harri
-
Jost, Philipp J.
-
Lindner, Lars H.
-
Bauer, Sebastian
-
Nilsson, Bengt
-
Kallio, Raija
-
Pesonen, Tommi
-
Reichardt, Peter
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Clinical Cancer ...
- Av lärosätet
-
Lunds universitet